• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关的胰岛素原加工变化在糖尿病和非糖尿病的日本个体中。

Age-related changes of proinsulin processing in diabetic and non-diabetic Japanese individuals.

机构信息

Diabetes Center, Shin-Suma Hospital, Kobe, Japan.

Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Toho University Graduate School of Medicine, Tokyo, Japan.

出版信息

Geriatr Gerontol Int. 2018 Jul;18(7):1046-1050. doi: 10.1111/ggi.13303. Epub 2018 Apr 17.

DOI:10.1111/ggi.13303
PMID:29665183
Abstract

AIM

The present study was carried out to examine whether the insulin secretory mechanism deteriorates during the aging process using the new intact proinsulin assay system in non-diabetic and diabetic individuals.

METHODS

A total of 172 participants were separated into four groups according to their age (<64 years and >65 years) and an association of type 2 diabetes; that is, 46 older diabetics (mean age 74.5 ± 6.2 years, glycated hemoglobin [National Glycohemoglobin Standardization Program] 7.5 ± 1.3%), 27 older non-diabetics (mean age 76.9 ± 7.5 years), 48 middle-aged diabetics (mean age 50.8 ± 10.4, glycated hemoglobin 7.8 ± 1.5%) and 51 middle aged non-diabetics (mean age 46.6 ± 13.0 years) participants were enrolled.

RESULTS

The proinsulin/insulin (PI/I) ratio of the diabetic group was higher than that of the non-diabetic group in the older group (0.19 ± 0.12 vs 0.11 ± 0.06, P = 0.002). In the middle-aged groups, the PI/I ratio of the diabetic group was higher than that of the non-diabetic group (0.16 ± 0.15 vs 0.09 ± 0.09, P = 0.003). Simple regression analysis showed that male sex (95% CI 0.02-0.01, P = 0.004), age (95% CI 0.00-0.002, P = 0.03), lower body mass index (95% CI -0.06 to 0.00, P = 0.02) and the presence of diabetes mellitus (95% CI 0.04-0.012, P < 0.0001) were significantly associated with the increase in the PI/I ratio. Multivariate regression analysis showed that male sex and age were the independent factors determining the increase in the PI/I ratio in the non-diabetic group. After adjusted for body mass index, the PI/I ratio correlated significantly with age only in the non-diabetic group (r = 0.5, P = 0.004).

CONCLUSIONS

The proinsulin processing system might deteriorate not only in diabetics, but also in non-diabetic Japanese individuals with age. Also, sex-related hormones can be protective for the proinsulin processing system. Geriatr Gerontol Int 2018; 18: 1046-1050.

摘要

目的

本研究旨在使用新的完整胰岛素原检测系统,在非糖尿病和糖尿病个体中,研究胰岛素分泌机制是否随年龄增长而恶化。

方法

根据年龄(<64 岁和>65 岁)和 2 型糖尿病的相关性,将 172 名参与者分为四组;即 46 名老年糖尿病患者(平均年龄 74.5±6.2 岁,糖化血红蛋白[全国糖化血红蛋白标准化计划]7.5±1.3%)、27 名老年非糖尿病患者(平均年龄 76.9±7.5 岁)、48 名中年糖尿病患者(平均年龄 50.8±10.4 岁,糖化血红蛋白 7.8±1.5%)和 51 名中年非糖尿病患者(平均年龄 46.6±13.0 岁)。

结果

老年组中,糖尿病组的胰岛素原/胰岛素(PI/I)比值高于非糖尿病组(0.19±0.12 比 0.11±0.06,P=0.002)。在中年组中,糖尿病组的 PI/I 比值高于非糖尿病组(0.16±0.15 比 0.09±0.09,P=0.003)。简单回归分析显示,男性(95%可信区间 0.02-0.01,P=0.004)、年龄(95%可信区间 0.00-0.002,P=0.03)、较低的体重指数(95%可信区间-0.06 至 0.00,P=0.02)和糖尿病(95%可信区间 0.04-0.012,P<0.0001)与 PI/I 比值升高显著相关。多元回归分析显示,男性和年龄是非糖尿病组 PI/I 比值升高的独立因素。调整体重指数后,非糖尿病组 PI/I 比值与年龄呈显著正相关(r=0.5,P=0.004)。

结论

胰岛素原加工系统不仅在糖尿病患者中恶化,而且在日本非糖尿病的老年个体中也恶化。此外,与性别相关的激素可能对胰岛素原加工系统有保护作用。老年医学与老年病学杂志 2018;18:1046-1050。

相似文献

1
Age-related changes of proinsulin processing in diabetic and non-diabetic Japanese individuals.年龄相关的胰岛素原加工变化在糖尿病和非糖尿病的日本个体中。
Geriatr Gerontol Int. 2018 Jul;18(7):1046-1050. doi: 10.1111/ggi.13303. Epub 2018 Apr 17.
2
Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.胰腺B细胞对衰老胰岛素抵抗的代偿能力降低:对胰岛素原和胰岛素水平的影响。
J Clin Endocrinol Metab. 2000 Jun;85(6):2275-80. doi: 10.1210/jcem.85.6.6635.
3
Are insulin and proinsulin independent risk markers for premature coronary artery disease ?胰岛素和胰岛素原是早发性冠状动脉疾病的独立风险标志物吗?
Diabetes. 1996 Jun;45(6):736-41. doi: 10.2337/diab.45.6.736.
4
Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.在患有非胰岛素依赖型糖尿病的皮马印第安人中,胰岛素原异常升高。
J Clin Endocrinol Metab. 1990 May;70(5):1247-53. doi: 10.1210/jcem-70-5-1247.
5
Plasma proinsulin in recently diagnosed type 2 diabetes mellitus.
Diabetes Res Clin Pract. 1993 May;20(2):133-8. doi: 10.1016/0168-8227(93)90007-r.
6
Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.胰岛素原水平不成比例地升高反映了非胰岛素依赖型糖尿病患者B细胞分泌能力受损的程度。
J Clin Endocrinol Metab. 1998 Feb;83(2):604-8. doi: 10.1210/jcem.83.2.4544.
7
Rosiglitazone, but not glyburide, reduces circulating proinsulin and the proinsulin:insulin ratio in type 2 diabetes.罗格列酮而非格列本脲可降低2型糖尿病患者的循环胰岛素原水平及胰岛素原与胰岛素的比值。
J Clin Endocrinol Metab. 2004 Dec;89(12):6048-53. doi: 10.1210/jc.2004-0705.
8
IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas.使用磺脲类药物治疗的2型糖尿病患者的白细胞介素-12血清水平。
Cytokine. 2008 Jun;42(3):312-6. doi: 10.1016/j.cyto.2008.02.014. Epub 2008 Apr 7.
9
Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus.糖耐量正常或轻度妊娠糖尿病孕妇中的胰岛素原
Exp Clin Endocrinol Diabetes. 1999;107(7):447-52. doi: 10.1055/s-0029-1212136.
10
Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men.TCF7L2基因的变异与β细胞功能障碍相关,并在瑞典老年男性ULSAM队列中增加了患2型糖尿病的风险。
Diabetologia. 2007 Sep;50(9):1852. doi: 10.1007/s00125-007-0746-5. Epub 2007 Jul 6.

引用本文的文献

1
Prominent Hyperproinsulinemia in a Middle Age Patient.一名中年患者出现显著的高胰岛素原血症。
Clin Med Insights Case Rep. 2021 Sep 1;14:11795476211042241. doi: 10.1177/11795476211042241. eCollection 2021.
2
Inside the Insulin Secretory Granule.在胰岛素分泌颗粒内部。
Metabolites. 2021 Aug 5;11(8):515. doi: 10.3390/metabo11080515.